2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z

Lack of Linguistically and Culturally Tailored Initiatives in Kidney Transplant Programs in the United States

S. Carbunaru¹, A. Ortiz², C. Ortiz³, J. Ortiz³, J. Locke⁴, J. Caicedo¹
Lack of Response to Tocilizumab in Kidney Transplants with Chronic Antibody-Mediated Rejection

D. Kumar¹, F. Safavi¹, R. Sandhu¹, P. Halloran², I. Yakubu¹, M. Levy¹, I. Moinuddin¹, P. Kimball¹, L. Kamal¹, A. King¹, H. Massey¹, G. Gupta¹
Laminin Dependent T Cell Migration Determines Allograft Survival

L. Li, M. Shirkey, W. Piao, Y. Xiong, V. Saxena, T. Zhang, B. M. Cerel, C. Paluskievicz, J. S. Bromberg
Laminin α5 Deficiency in Lymph Node Stromal Cells Promotes Treg Migration and Allograft Survival

L. Li, M. Shirkey, W. Piao, Y. Xiong, V. Saxena, T. Zhang, T. Simon, N. Toney, C. Paluskievicz, J. S. Bromberg
Large Series Of Liver Transplantation In Patients With Portal Vein Thrombosis

Y. Cheah, C. J. Simon, R. L. Jenkins, M. E. Akoad
Late Acute Rejection Increases Risk Of Graft Failure In Ldlt Recipients: Data From The A2all Cohort

H. J. Braun, J. L. Dodge, J. D. Grab, S. M. Syed, G. R. Roll, C. E. Freise, J. P. Roberts, N. L. Ascher
Late Onset J C Virus Allograft Nephropathy

M. Samra, I. Tang, S. Setty
LCP-Tacrolimus (LCPT; Envarsus XR) Dosing Considerations in De Novo Kidney Transplant Recipients

D. Cibrik¹, P. West-Thielke², S. J. Patel³, D. R. Stevens⁴, U. Meier-Kriesche⁴
Learning Curve for Living Donor Laparoscopic Left Lateral Sectionectomy

R. Hwang¹, D. von Ahrens², A. Griesemer¹, T. Kato¹, J. Emond¹, D. Cherqui³, B. Samstein²
Letermovir for CMV Treatment in Solid Organ Transplant

O. Witkowsky, M. Chunduru, A. Chung, A. Diez
Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients

M. R. Pereira¹, J. G. Aaron¹, C. J. Kubin²
Leukopenia at the Time of Liver Transplantation: Medication Tolerance and Clinical Outcomes

E. Tiao¹, J. Casale¹, J. LaMattina², S. Hammad¹
Leukopenia in Older Kidney Transplant Recipients is Associated with Decreased Allograft Survival and Increased Patient Survival

R. Rodriguez, A. Price, K. Soliman, R. Vinaya, D. Lazarus, M. Casey, M. Labonte, L. Erbe, M. Shearer, D. Taber, M. Posadas Salas
Lifelong Immunosuppression, I Am Sure We Told Them That?: Long Term Medication Adherence in Liver Transplant Patients

K. Foster¹, C. Perez¹, T. Harrison¹, H. Corbo¹, N. Patel¹, J. Fleming¹, H. Meadows¹, D. Taber¹, D. DuBay², J. McGillicuddy², N. Pilch¹
Ligation Of Hla Class Il Molecules Disrupts Endothelial Barrier Through Src-dependent Ve-cadherin Destabilization

F. Li¹, R. A. Sosa¹, N. M. Valenzuela¹, E. Rozengurt², E. F. Reed¹
Ligation of the Proximal Splenic Vein to Keep Adequate Portal Flow in Patients with Large Splenorenal Shunts during Living Donor Liver Transplantation

C. Cheng
Limited Accessibility of Kidney Transplantation in Rural Residents: A Nationwide Data of South Korea

J. Kim¹, K. Park¹, S. Park¹, M. Yu², Y. Kim¹, J. Jeong¹, K. Kim¹, M. Park³, H. Lee¹
Lineage Tracing Identifies C-Kit Cells as a Population of Kidney-Specific Stem Cells during Development and in Acute and Chronic Kidney Diseases

E. B. Rangel¹, E. Higuti-Sousa¹, G. Goss², B. Goldstein², B. Seidler³, D. Saur³, S. A Gomes⁴, J. M. Hare²
Liquid Biopsy for Chronic Rejection after Kidney Transplantation. A Novel Non-Invasive Biomarker Involved in Inflammatory Amplifier

Y. Takada¹, D. Kamimura², H. Higuchi¹, D. Iwami¹, K. Hotta¹, N. Iwahara¹, N. Shinohara¹, M. Murakami²
Listening to the Patients Voice for Developing Transplant Education

S. Brown, H. Li, D. Tsapepas
Listing Practices and Graft Utilization Lag behind Supply of Hepatitis C Positive Deceased Donors for Liver and Kidney Transplant

C. E. Kling¹, J. D. Perkins², S. W. Biggins³, C. Johnson⁴, A. P. Limaye⁵, L. Sibulesky¹
Liver Allograft Provides Protection Against Cardiac Allograft Rejection In Combined Heart And Liver Transplantation

K. Zhao¹, R. Wang², M. Kamoun³, K. Olthoff¹, M. Hoteit⁴, E. Rame⁵, M. Levine¹, R. Mclean⁵, P. Abt¹
Liver Circle-Based Allocation: LSAM Modeling Results

D. Schladt¹, T. Weaver¹, J. Pyke¹, A. Herreid¹, B. Thompson¹, B. Kasiske¹, J. Snyder¹, W. Kim², J. Lake³, A. Israni¹, J. Heimbach⁴
Liver Transplant Candidate Attitudes towards Organs from Increased Risk Donors: A Single Center Survey

S. S. Humar, J. Liu, N. Pinzon, D. Kumar, M. Bhat, L. Lilly, N. Selzner
Liver Transplant Candidates Derive a Survival Benefit from Accepting a Macrosteatotic Liver

K. Jackson, M. Bowring, C. Haugen, C. Holscher, L. Liyanage, S. Ottmann, B. Philosophe, A. Massie, D. Segev, A. Cameron, J. Garonzik-Wang
Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center

C. R. Schaffhausen¹, M. J. Bruin², S. Chu², D. Schladt¹, S. Chinnakotla³, J. R. Lake⁴, W. Kim⁵, S. W. Biggins⁶, J. J. Snyder⁷, B. L. Kasiske⁷, A. K. Israni¹
Liver Transplant Outcomes in Patients with Atrial Fibrillation

D. Devuni¹, P. Mahboub², P. Martins², C. Barry¹, I. Zacharias¹, B. Movahedi², G. Barnard¹, A. Bozorgzadeh²
Liver Transplantation for Acute Liver Failure: A 16 Year Experience with 214 Patients in the Post-MELD Era

R. McMillan, T. Ito, A. Aziz, A. Amin, A. Murray, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib

A. I. David¹, D. N. Alvarenga de Rezende², M. C. Fantauzzi³, T. Di Santi³, N. C. Confuorto³, G. T. Martinho³, P. S. Antunes³
Liver Transplantation in Children with Type 1 and Type 2 Autoimmune Hepatitis

I. G. Roepe, J. A. Goss, T. Miloh
Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates

D. Schladt¹, T. Weaver¹, J. Pyke¹, A. Herreid¹, B. Thompson¹, B. Kasiske¹, J. Snyder¹, W. Kim², J. Lake³, A. Israni¹
Living Donor Conversion Rates as a Quality Measure for Kidney Program Efficiency for Both New Referrals and Existing Listed Candidates

E. Woodle¹, C. Siemers², B. Woodle³, C. King², R. Alloway¹, S. Tremblay¹
Living Donor Kidney Transplantation. Overcoming Sex Disparity In Japan

M. Yoshikawa
Living Donor Renal Transplantation without Any Induction Immunosuppression in Spousal Donors – Single Center Experience

R. Bhat, F. Aziz, I. N. Abubecker, S. Narayanan, B. Hafeeque
Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease

G. Gu, Q. Xia
Living Kidney Donor Time Zero Biopsy Findings Predict Graft Loss in the Recipient

N. Issa¹, C. Lopez¹, A. Denic¹, J. J. Larson¹, R. Narasimhan¹, L. Archila¹, S. S. Taler¹, H. Chakkera², J. Augustine³, M. Stegall⁴, A. Rule¹
Living Kidney Donors Who Lose Weight in Order to Be Able to Donate, Gain More Weight after Donation

S. R. Punjala, L. Silas, R. Gokmen, N. Karydis
Local IL-33 Regulates Heart Transplant Infiltrating Myeloid Cells Metabolism and Differentiation to Protect against Chronic Rejection

Z. Zhang¹, Q. Liu¹, T. Li¹, G. S. Hussey², M. Velayutham¹, J. L. Dziki², L. R. Mathews¹, Y. C. Lee², G. K. Dwyer¹, H. Dai¹, A. S. Roessing¹, S. Shiva³, M. H. Oberbarnscheidt¹, S. F. Badylak², H. R. Turnquist¹
Long Term Cold Ischemia Time in Kidney Transplantation. The Role of Hypothermic Machine Perfusion

G. ADANI¹, U. Baccarani¹, P. Tulissi², C. Vallone², A. Risaliti¹
Long Term Follow-Up of the Use of Checkpoint Inhibitors in Kidney Transplant Recipients

K. Venkatachalam, R. Delos Santos, T. Alhamad
Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation

G. Kelly¹, J. L. Pasko¹, E. Dewey², E. Maynard¹, S. L. Orloff¹, C. Enestvedt¹
Long Term Outcomes in Kidney Transplant Recipients Receiving Everolimus (EVR) or Mycophenolate (MPS) in Combination with Tacrolimus (TAC)

K. Ficher, C. Rosso Felipe, Y. Cardoso Dreige, K. Linhares, A. Ferreira Brígido, S. Stopa, L. Viana, M. Cristelli, P. Gessolo Lins, W. Aguiar, H. Proença, R. Marco, M. Gerbase de Lima, H. Tedesco Silva Junior, J. Medina Pestana
Long Term Outcomes of Patients Transplanted for Hepatocellular Carcinoma with Human Immunodeficiency Virus Infection

R. Gedaly-Eidelman, E. Chacon, P. Eman, M. Gupta, J. Berger, A. El-Husseini, X. Mei, F. Marti, L. Turcios, M. Shah
Long Term Outcomes Using Tocilizumab For The Treatment Of Chronic Antibody Mediated Rejection

J. Choi¹, E. Huang¹, O. Aubert², A. Vo¹, A. Peng¹, R. Najjar¹, S. Sethi¹, N. Ammerman¹, K. Lim¹, D. Puliyanda¹, A. Loupy², S. Jordan¹
Long Term Renal Function Following Islet Transplantation in the Clinical Islet Transplantation Consortium

L. G. Hunsicker¹, T. L. Eggerman², M. R. Rickels³, t. Clinical Islet Transplantation (CIT) Consortium⁴
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 10 Years Follow-Up

Y. Watarai¹, S. Narumi¹, T. Tomosugi¹, K. Futamura², M. Okada¹, M. Tsujita², T. Hiramitsu¹, T. Kobayashi³, N. Goto²
Long-Term Efficacy of Direct-Acting Antiviral Agents

J. Zhang, W. Sun, J. Lin, Y. Tian, L. Ma, L. Zhang, Y. Zhu
Long-Term Exposure to Particulate Matter Air Pollution and the Risk of Graft Failure and Mortality in Kidney Transplant Recipients

Y. Kim¹, S. Kwon¹, J. Park², J. Lee³
Long-term Impact of Antihypertensive Treatment and Tacrolimus Dose in Renal Allograft Recipients 5 Years Post-Transplantation

D. Rush¹, S. Cockfield², S. Wilson³, J. Schwartz⁴
Long-Term Influence of Arteriosclerosis in Kidney Grafts Proven by a Zero-Hour Biopsy

Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida¹, K. Tanabe¹
Long-Term Kidney Graft Evolution in Simultaneous Liver-Kidney Transplants with Immunological Risk

G. J. Piñeiro¹, E. Montagud¹, J. Ugalde¹, R. Gelpi¹, V. Torregrosa¹, J. Rovira², J. Colmenero³, F. Diekmann¹, N. Esforzado¹
Long-Term Outcome and Surgical Complications Following Live-Donor Kidney Transplantation in Children Weighting Less Than 15 Kg: A Single Center Experience in Japan

Y. Aoki¹, H. Satoh², Z. Matsui², R. Hamada³, R. Harada³, M. Muramatsu⁴, Y. Hamasaki⁴, S. Shishido⁴
Long-Term Outcomes after Face Transplantation

B. Kollar, S. Tasigiorgos, M. Turk, E. Bueno, B. Perry, M. Alhefzi, H. Kiwanuka, M. Nizzi, N. Krezdorn, T. Win, M. I. Dorante, V. Haug, D. J. Annino, F. M. Marty, A. Chandraker, S. G. Tullius, L. V. Riella, B. Pomahac
Long-Term Outcomes and Safety of Living Kidney Transplantation from Older Donors

Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
Long-term Outcomes And The Feasibility Of Kidney Retransplantation In Pediatric Survivors Of Post-transplant Lymphoproliferative Disease

S. Kizilbash, P. Verghese, B. Chavers
Long-Term Outcomes Following Uncontrolled Donation after Cardiac Death Kidney Transplantation: Opportunity for Increasing Donor Pool?

R. A. Choudhury, K. Prins, D. Yoeli, H. B. Moore, T. L. Nydam
Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy

A. Kassam, A. Mirza, Y. Kim, E. S. Woodle, S. A. Shah, M. C. Cuffy, R. C. Quillin III, L. Sage Silski, A. Govil, M. Cardi, T. S. Diwan
Long-Term Outcomes of Early Conversion to Sirolimus-Based Immunosuppression in Children with Living Donor Kidney Transplants

B. Stotter¹, S. Lui¹, E. Weller², L. Ganapathi¹, M. Ferguson¹, A. Traum¹, M. Somers¹, N. Rodig¹
Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies

C. Schinstock, A. Bentall, S. Byron, L. Cornell, M. Everly, M. Gandhi, M. Stegall
Long-Term Outcomes of Elderly Living Donors: A Nationwide Population-Based Study

H. Yoon¹, Y. Kim², S. Shin¹, J. Ahn³, C. Yang¹, B. Chung¹
Long-Term Outcomes of Older Kidney-Transplant Recipients: A Single-Center Experience

S. Sultan, M. Aull, M. Lubetzky, A. Watkins, S. Kapur
Long-Term Survival after Kidney-Pancreas Transplantation: Lessons from World Largest Series of Long-Term Survivors

S. Parajuli, F. Aziz, N. Garg, B. Muth, A. Djamali, R. Redfield, D. Kaufman, J. Odorico, D. Mandelbrot, H. Sollinger
Long-Term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant

J. Kim¹, D. Lee¹, J. Oh¹, J. Lee¹, H. Kim¹, Y. Son²
Longer-Term Outcomes for Hepatitis C Virus Negative Recipients of Kidneys from Hepatitis C Virus Nucleic Acid Test Positive Donors: The THINKER Trial

P. Reese¹, P. Abt¹, E. Blumberg¹, R. Bloom¹, D. Sawinski¹, P. Porrett¹, A. Woodards¹, K. Reddy¹, V. van Deerlin¹, R. Hasz², M. Levine¹, R. McLean¹, A. Sicilia¹, D. Goldberg¹
Loss of FXR Exacerbates Liver Damage by Activating NLRP3 Inflammasome Induced Pyroptosis in Liver Ischemia Reperfusion Injury

Z. Zhu, Y. Zhang, Y. Tang, S. Huang, Q. Zhao, W. Ju, Z. Guo, X. He
Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant

P. W. Baron¹, J. Weissman², F. Fazeli³, C. Zuppan⁴, R. Villicana³, P. Wai¹, L. Beeson⁵, M. De Vera¹
Low Dose Thymoglobulin Has No Disadvantages to Standard Higher Dose: A Report of the Midwest Pediatric Nephrology Consortium

I. Ashoor¹, R. Beyl², C. Gupta³, A. Jain⁴, S. Kiessling⁵, H. Patel⁶, J. Sherbotie⁷, D. J. Weaver Jr⁸, R. Zahr⁹, V. Dharnidharka¹⁰
Low Frequency Of Canonical Human Leukocyte Antigen Alloimmunization In Heart Transplantation Candidates With Ventricular Assist Devices

G. K. Mahowald¹, S. L. Saidman¹, G. Lewis², V. Pattanayak¹
Low Incidence of Acute Renal Failure with Minimal Prophylaxis after Iodinated-Contrast TC in Ambulatory Renal Transplant Patients

C. Jimenez¹, S. Afonso¹, M. O. Lopez¹, M. E. Gonzalez¹, M. J. Santana¹, A. Santiago², M. A. Vaca¹, M. Ferreira¹, R. Selgas¹
Low Specific Gravity Of First Morning Urine Predicts Bkvn in Kidney Transplant Recipients With Bk Viruria

G. Huang¹, X. Chen¹, Z. Wang², Y. Nuertai², W. Chen³, S. Yang³, P. Chen⁴, C. Wang¹
Low-Dose Valacyclovir Prophylaxis for Cytomegalovirus Infection in Renal Transplant Recipients with Intermediate Risk

A. Velioglu¹, H. Arikan¹, E. Asicioglu¹, S. Alagoz², N. Seyahi², S. Tuglular¹, C. Ozener¹
Lower Alcohol Taxes Are Associated with Increased Liver Transplant Listing

N. T. Shen¹, M. Raver¹, N. Hutchison¹, A. Jesudian¹, J. Bray², B. Schackman³, R. S. Brown¹
Lower Extremity Impairment and Frailty among Adults with Diabetes Awaiting Kidney Transplantation

E. Lorenz, A. Kukla, C. Kennedy, R. McCoy, L. Hickson
Lower Incidence of Posttransplant Malignancies under Vitamin D (Calcidiol) Treatment in Kidney Transplantation

I. Revuelta¹, V. Tubita², J. Ugalde¹, D. Cucchiari¹, F. Oppenheimer¹, F. Diekmann¹, J. Campistol¹, J. Torregrosa¹
Lower Rates of Epstein-Barr Virus Viremia and Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients Who Received Valganciclovir Prophylaxis

E. A. Moulton¹, M. Karandikar², S. Bond³, S. Burchett², T. Sharma², F. M. Marty³
Lower Stanford Integrated Psychosocial Assessment (SIPAT) for Transplantation Score is Predictive of Successful Listing for Kidney Transplant Candidates

A. Kumar¹, J. Salaway², M. Dorris², J. Newman³, A. Doyle¹, S. Rao¹
Lung Allocation Score Should Be Implemented in China

C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He
Lung Transplant Outcomes after CABG

S. Huddleston¹, R. Aggarwal¹, S. Jackson², N. Lemke¹
Lung Transplantation in the Elderly Patients with Multi-Comorbidities

N. Shigemura, Y. Toyoda
Lymphotoxin Beta Receptor Determines Lymph Node Structure for Treg Migration and Suppression of Graft Rejection

V. Saxena, W. Piao, L. Li, C. M. Paluskievicz, Y. Xiong, T. Simon, J. S. Bromberg
Lymphotoxin Beta Receptor in Lymphatic Endothelial Cells Regulates Treg Migration and Allograft Protection

V. Saxena, W. Piao, L. Li, C. M. Paluskievicz, Y. Xiong, T. Simon, J. S. Bromberg
Lymphotoxin Signaling Regulates T Cell Lymphatic Trafficking

W. Piao¹, L. Li², V. Saxena², Y. Xiong², M. WillsonShirkey², C. Paluskievicz², J. Bromberg³

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z